To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NCAPGTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
367 supporting clones for gene NCAPG back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB451361 testis .a 1 to 496 1 to 496   tiling clone,   496/496
(100 %)
1 diff
(99.8 %id)
DB064997 testis .a 25 to 559 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
DB060627 testis .a 31 to 612 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
AF331796   .a 90 to 3398 1 to 3309 exact tiling clone, AAA   3309/3309
(100 %)
2 diff
(100.0 %id)
NM_022346.3   .a 90 to 4750 1 to 4661 exact RefSeq, AAA   4661/4661
(100 %)
0 diff
(100 %id)
DB076622 testis .a 118 to 666 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DB088632 testis .a 118 to 666 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
AB013299   .a 127 to 3396 1 to 3270 exact AAA   3270/3270
(100 %)
2 diff
(100.0 %id)
DA700472   .a 131 to 614 2 to 486   capped   485/485
(100 %)
2 diff
(99.6 %id)
DA028081   .a 147 to 697 26 to 576   capped   551/575
(95 %)
6 diff
(99.0 %id)
DA475110   .a 148 to 699 2 to 553   capped   552/552
(100 %)
3 diff
(99.5 %id)
BQ440536 leiomyosarcoma, uterus .a 149 to 1023 1 to 886       886/941
(94 %)
26 diff
(97.3 %id)
DB099644 testis .a 149 to 725 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DB132264 thymus .a 149 to 712 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
DA435788 tongue, tumor tissue .a 150 to 718 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB074097 testis .a 150 to 688 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DB098319 testis .a 150 to 713 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB157226 thymus .a 150 to 730 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DB073802 testis .a 151 to 708 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB079923 testis .a 151 to 725 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB085682 testis .a 151 to 708 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DB093953 testis .a 151 to 695 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
DB151368 thymus .a 151 to 718 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BG773234 testis .a 156 to 813 1 to 657       657/657
(100 %)
7 diff
(99.0 %id)
DA903489   .a 160 to 741 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DB450581 testis .a 161 to 601 1 to 442       442/442
(100 %)
7 diff
(98.5 %id)
DB154721 thymus .a 162 to 729 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
CN309912 embryonic stem cells, cell lines H1, H7, andH9 .a 166 to 680 1 to 515       515/515
(100 %)
4 diff
(99.3 %id)
DA738011   .a 168 to 928 2 to 763   capped   762/762
(100 %)
4 diff
(99.5 %id)
BP363777 lung .a 168 to 751 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
AK022512   .a 170 to 3396 1 to 3227 R115G D676V K681R V704A available from FLJ,   3227/3227
(100 %)
7 diff
(99.8 %id)
BP246239 Kidney .a 170 to 745 1 to 576       576/582
(98 %)
2 diff
(99.7 %id)
DA022629   .a 171 to 732 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
CN309922 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 171 to 888 1 to 718       718/718
(100 %)
4 diff
(99.5 %id)
DA547706   .a 171 to 744 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA618486   .a 171 to 743 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
AU122960   .a 171 to 773 2 to 612   capped   611/733
(83 %)
17 diff
(97.7 %id)
DA810534 brain .a 171 to 715 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
DA861797 placenta .a 171 to 738 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA904043   .a 171 to 724 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DB022349 testis .a 171 to 655 2 to 486   capped   485/485
(100 %)
0 diff
(100 %id)
DB053542 testis .a 171 to 733 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB079367 testis .a 171 to 744 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DB132707 thymus .a 171 to 717 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
DB132864 thymus .a 171 to 646 2 to 477   capped   476/478
(99 %)
5 diff
(99.0 %id)
DB161236 thymus .a 171 to 761 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
BF663520 B-cells, primary B-cells from tonsils (cell line) .a 172 to 800 1 to 627       627/627
(100 %)
9 diff
(98.6 %id)
BX474610   .a 174 to 795 1 to 622   tiling clone,   622/622
(100 %)
1 diff
(99.9 %id)
BX494242 Liver .a 175 to 713 1 to 539       539/539
(100 %)
2 diff
(99.7 %id)
BX492958   .a 177 to 713 1 to 537       537/537
(100 %)
1 diff
(99.9 %id)
DA614238   .a 177 to 614 2 to 440   capped   439/439
(100 %)
2 diff
(99.6 %id)
DB142856 thymus .a 177 to 706 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
DA558332   .a 178 to 746 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA740101   .a 178 to 666 2 to 490   capped   489/489
(100 %)
2 diff
(99.6 %id)
DN997875 breast cancer, Mammary gland (cancer tissue) .a 178 to 887 1 to 710       710/710
(100 %)
5 diff
(99.3 %id)
BG717011 testis .a 179 to 809 1 to 633       633/638
(99 %)
9 diff
(98.6 %id)
DA481177   .a 180 to 728 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA907035   .a 180 to 747 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DA651269   .a 181 to 731 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
BC068467 testis .a 184 to 3399 1 to 3216 E91V L361S E543G I645T available from MGC, AAA   3216/3216
(100 %)
8 diff
(99.8 %id)
CN309916 embryonic stem cells, cell lines H1, H7, andH9 .a 185 to 747 1 to 563       563/563
(100 %)
1 diff
(99.9 %id)
BM454618 embryonal carcinoma, cell line, testis .a 188 to 1154 1 to 981       981/1035
(94 %)
28 diff
(97.3 %id)
CN309911 embryonic stem cells, DMSO-treated H9 cellline .a 190 to 910 1 to 721       721/721
(100 %)
3 diff
(99.6 %id)
BU509786 leiomyosarcoma, uterus .a 193 to 916 1 to 733       733/883
(83 %)
15 diff
(98.4 %id)
CN309913 embryonic stem cells, cell lines H1, H7, andH9 .a 194 to 825 1 to 632       632/632
(100 %)
6 diff
(99.1 %id)
AL556779 placenta .a 197 to 934 1 to 740       740/740
(100 %)
11 diff
(98.6 %id)
AF235023   .a 198 to 3395 1 to 3198 F276V M581I E1000X N1005X L1010F     3198/3198
(100 %)
4 diff
(99.9 %id)
BP285498 lung .a 202 to 783 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
DA019295   .a 203 to 752 2 to 554   capped   553/553
(100 %)
3 diff
(99.5 %id)
DA750359   .a 203 to 756 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
CN309918 embryonic stem cells, cell lines H1, H7, andH9 .a 207 to 969 1 to 763       763/763
(100 %)
3 diff
(99.7 %id)
BX476064   .a 207 to 709 1 to 504       504/504
(100 %)
4 diff
(99.3 %id)
TI_927043229   .a 212 to 1168 96 to 1041     Submitted on the opposite strand 946/1167
(81 %)
16 diff
(98.7 %id)
TI_927043230   .a 212 to 1071 95 to 951     Submitted on the opposite strand 857/1179
(72 %)
12 diff
(99.0 %id)
BC101476 Lung and heart, PCR rescued clones .a 213 to 3336 1 to 3124 exact     3124/3124
(100 %)
1 diff
(100.0 %id)
BU161417 melanotic melanoma, skin .a 224 to 1036 1 to 814       814/877
(92 %)
3 diff
(99.7 %id)
CN309915 embryonic stem cells, cell lines H1, H7, andH9 .a 230 to 843 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
DA545188   .a 241 to 792 2 to 555   capped   554/554
(100 %)
3 diff
(99.5 %id)
DA504992 brain .a 261 to 809 2 to 551   capped   550/558
(98 %)
1 diff
(99.9 %id)
CN309919 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 264 to 902 1 to 639       639/640
(99 %)
1 diff
(99.9 %id)
TI_1948231769   .a 265 to 1191 133 to 1057       925/1338
(69 %)
39 diff
(97.1 %id)
TI_1948231770   .a 265 to 1188 124 to 1050       927/1064
(87 %)
21 diff
(98.1 %id)
EL736885 mixed .a 266 to 869 1 to 604       604/604
(100 %)
1 diff
(99.9 %id)
CN309910 embryonic stem cells, cell lines H1, H7, andH9 .a 270 to 782 1 to 513       513/513
(100 %)
0 diff
(100 %id)
BF795312 lymph, lymphoma, cell line .a 336 to 1112 1 to 774       774/1038
(74 %)
15 diff
(98.6 %id)
BI253340 cervical carcinoma cell line, cervix .a 354 to 1180 1 to 832       832/846
(98 %)
8 diff
(99.1 %id)
BU159085 embryonal carcinoma, cell line, testis .a 355 to 1168 1 to 817       817/914
(89 %)
14 diff
(98.5 %id)
BF335229 colon .a 367 to 614 248 to 1       248/248
(100 %)
3 diff
(98.8 %id)
AU128268   .a 384 to 1001 2 to 621   capped   620/620
(100 %)
8 diff
(98.8 %id)
AK023147   .a 420 to 3399 1 to 2980   available from FLJ,   2980/2980
(100 %)
3 diff
(99.9 %id)
AU131153   .a 421 to 1234 2 to 815   capped   814/859
(94 %)
8 diff
(99.1 %id)
DA020160   .a 440 to 1000 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
TI_927043837   .a 448 to 1661 1 to 1196       1198/1240
(96 %)
24 diff
(98.1 %id)
DR763649 embryonic stem .a 458 to 1326 1 to 868       868/868
(100 %)
1 diff
(99.9 %id)
BP314176 mammary gland .a 476 to 1057 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DB153995 thymus .a 486 to 1072 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
TI_927043845   .a 621 to 1772 14 to 1167       1154/1248
(92 %)
21 diff
(98.4 %id)
BU429230 lymph .a 622 to 809 1 to 188       188/192
(97 %)
6 diff
(96.9 %id)
BG425405 Kidney, renal cell adenocarcinoma .a 637 to 1327 1 to 690       690/691
(99 %)
14 diff
(98.0 %id)
CR747748 melanotic melanoma, skin .a 717 to 1204 12 to 499       488/499
(97 %)
7 diff
(98.6 %id)
BQ232101 melanotic melanoma, skin .a 718 to 1582 1 to 869       869/880
(98 %)
10 diff
(98.9 %id)
BG898785 cartilage .a 731 to 1059 87 to 415       329/346
(95 %)
6 diff
(98.3 %id)
CN309921 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 763 to 1337 1 to 574       574/574
(100 %)
3 diff
(99.5 %id)
BF371033 prostate_normal .a 776 to 1193 420 to 6       415/420
(98 %)
0 diff
(100 %id)
BP363395 lung .a 793 to 1373 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BF371035 prostate_normal .a 800 to 1205 409 to 6       404/409
(98 %)
0 diff
(100 %id)
AU128657   .a 823 to 1545 2 to 728   capped   727/731
(99 %)
12 diff
(98.4 %id)
TI_927043838   .a 859 to 2029 1 to 1158       1158/1256
(92 %)
24 diff
(98.1 %id)
BF103741 embryonal carcinoma, testis .a 892 to 1593 1 to 700       700/739
(94 %)
26 diff
(96.5 %id)
DA903808   .a 899 to 1456 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
BP238750 Liver .a 951 to 1547 1 to 597       597/597
(100 %)
1 diff
(99.9 %id)
TI_927043839   .a 1000 to 2170 7 to 1169       1163/1247
(93 %)
28 diff
(97.8 %id)
BP238393 Liver .a 1038 to 1618 1 to 581       581/581
(100 %)
7 diff
(98.8 %id)
DA801164 brain .a 1040 to 1589 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
AW194979 Kidney .a 1073 to 1814 742 to 1       742/742
(100 %)
10 diff
(98.7 %id)
BG527196 lung, mucoepidermoid carcinoma .a 1097 to 1736 1 to 642       642/750
(85 %)
5 diff
(99.4 %id)
BX495203 Liver .a 1113 to 1548 1 to 436       436/436
(100 %)
13 diff
(97.1 %id)
BE889290 leiomyosarcoma, uterus .a 1129 to 1818 1 to 687       687/902
(76 %)
10 diff
(98.9 %id)
BM796308 stomach .a 1147 to 1548 1 to 402       402/402
(100 %)
17 diff
(95.8 %id)
CN309920 embryonic stem cells, DMSO-treated H9 cellline .a 1159 to 1673 1 to 514       514/514
(100 %)
3 diff
(99.5 %id)
BI094436 cervix .a 1198 to 1962 1 to 769       769/769
(100 %)
13 diff
(98.4 %id)
DA817736   .a 1200 to 1756 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AU126032   .a 1299 to 2127 2 to 828   capped   827/832
(99 %)
10 diff
(98.8 %id)
AU129281   .a 1302 to 1863 2 to 564   capped   563/563
(100 %)
7 diff
(98.8 %id)
AU119856 whole embryo, mainly head .a 1310 to 2150 2 to 837   capped   836/846
(98 %)
8 diff
(99.1 %id)
BQ951725 leiomyosarcoma, uterus .a 1312 to 2241 1 to 933       931/933
(99 %)
17 diff
(98.2 %id)
TI_927043834   .a 1328 to 2530 1 to 1199       1199/1246
(96 %)
25 diff
(98.0 %id)
DA603336   .a 1331 to 2139 2 to 817   capped   816/937
(87 %)
12 diff
(98.8 %id)
BP282718 bone marrow .a 1332 to 1915 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
DA049423   .a 1347 to 1930 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
AU125409   .a 1365 to 2151 2 to 785   capped   784/844
(92 %)
8 diff
(99.1 %id)
TI_927043840   .a 1389 to 2493 15 to 1118       1104/1238
(89 %)
17 diff
(98.7 %id)
BI088757 cervix .a 1418 to 2233 1 to 816       816/816
(100 %)
11 diff
(98.7 %id)
CB107197 Liver .a 1455 to 1935 1 to 482       482/482
(100 %)
2 diff
(99.6 %id)
CN309917 embryonic stem cells, cell lines H1, H7, andH9 .a 1481 to 1935 1 to 455       455/455
(100 %)
2 diff
(99.6 %id)
DA610795   .a 1489 to 2056 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BI086531 cervix .a 1512 to 2377 1 to 878       878/905
(97 %)
34 diff
(96.3 %id)
BP272157   .a 1548 to 2143 1 to 596       596/596
(100 %)
6 diff
(99.0 %id)
BM472288 melanotic melanoma, skin .a 1590 to 2328 42 to 786       745/1010
(73 %)
30 diff
(97.1 %id)
CB127449 cervix, Uterine .a 1610 to 2065 1 to 456       456/456
(100 %)
0 diff
(100 %id)
AW674070 cervix .a 1617 to 1969 1 to 355       355/355
(100 %)
2 diff
(99.5 %id)
TI_927043835   .a 1650 to 2828 7 to 1178       1172/1255
(93 %)
20 diff
(98.5 %id)
AK027511   .a 1664 to 4750 1 to 3087   tiling clone, available from FLJ,   3087/3087
(100 %)
5 diff
(99.9 %id)
AU126259   .a 1665 to 2455 2 to 795   capped   794/794
(100 %)
7 diff
(99.2 %id)
CB149647 Liver .a 1695 to 2245 1 to 551       551/551
(100 %)
0 diff
(100 %id)
AW401913 lymph .a 1697 to 2108 8 to 419       412/419
(98 %)
6 diff
(98.6 %id)
TI_154138156   .a 1697 to 2283 80 to 666       587/588
(99 %)
9 diff
(98.5 %id)
BM457013 embryonal carcinoma, cell line, testis .a 1701 to 2375 1 to 677       677/1080
(62 %)
16 diff
(98.6 %id)
BI089679 cervix .a 1703 to 2415 1 to 714       714/804
(88 %)
10 diff
(98.8 %id)
BM452029 eye, retinoblastoma .a 1725 to 2597 1 to 879       879/925
(95 %)
11 diff
(98.9 %id)
BQ232217 melanotic melanoma, skin .a 1725 to 2567 1 to 847       847/873
(97 %)
14 diff
(98.4 %id)
TI_927043841   .a 1766 to 2893 1 to 1129       1129/1274
(88 %)
7 diff
(99.5 %id)
BF572742 melanotic melanoma, high MDR, skin .a 1790 to 2255 1 to 465   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 465/774
(60 %)
13 diff
(98.4 %id)
BF700363 brain, primitive neuroectoderm .a 1804 to 2504 1 to 683       687/830
(82 %)
42 diff
(95.0 %id)
BQ427449 melanotic melanoma, skin .a 1826 to 2695 1 to 885       885/885
(100 %)
16 diff
(98.2 %id)
CB164580 thymus .a 1866 to 2386 1 to 521       521/521
(100 %)
1 diff
(99.9 %id)
BI090449 cervix .a 1873 to 2536 1 to 671       671/673
(99 %)
16 diff
(97.7 %id)
BC000827 Placenta, choriocarcinoma .a 1913 to 3388 1 to 1476   available from MGC, AAA   1476/1476
(100 %)
0 diff
(100 %id)
BG825593 muscle, rhabdomyosarcoma .a 1914 to 2618 1 to 704       704/704
(100 %)
9 diff
(98.8 %id)
BP225422   .a 1919 to 2500 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BE538430 cervix .a 1933 to 2476 1 to 575   available from MGC,   494/580
(85 %)
34 diff
(94.2 %id)
BX482587   .a 1963 to 2576 1 to 613       613/613
(100 %)
3 diff
(99.6 %id)
BM457795 lymph, lymphoma, cell line .a 1966 to 2784 8 to 831       824/878
(93 %)
19 diff
(97.9 %id)
DB055339 testis .a 1966 to 2444 2 to 483   capped   482/482
(100 %)
3 diff
(99.4 %id)
TI_1948079247   .a 1996 to 2887 121 to 995       875/1080
(81 %)
43 diff
(96.1 %id)
TI_1948078903   .a 2005 to 2857 126 to 970       845/1088
(77 %)
32 diff
(97.1 %id)
TI_1948078904   .a 2005 to 2727 129 to 850       722/1372
(52 %)
21 diff
(98.5 %id)
TI_1948079595   .a 2005 to 2732 132 to 859       728/1103
(66 %)
22 diff
(98.1 %id)
TI_1948079596   .a 2005 to 2839 129 to 971       843/1471
(57 %)
33 diff
(97.8 %id)
TI_1948079945   .a 2005 to 2836 128 to 966       837/1126
(74 %)
35 diff
(96.9 %id)
TI_1948079946   .a 2005 to 2891 126 to 1010       885/1380
(64 %)
18 diff
(98.7 %id)
CV029780 mixed .a 2006 to 2626 1 to 621       621/621
(100 %)
0 diff
(100 %id)
BG335809 choriocarcinoma, placenta .a 2017 to 2750 1 to 721       723/928
(77 %)
35 diff
(96.3 %id)
BG336188 choriocarcinoma, placenta .a 2017 to 2792 1 to 762       764/968
(78 %)
28 diff
(97.2 %id)
BG336195 choriocarcinoma, placenta .a 2017 to 2782 1 to 747       747/961
(77 %)
28 diff
(97.1 %id)
AA496777   .a 2021 to 2344 1 to 324       324/324
(100 %)
0 diff
(100 %id)
BE278549 choriocarcinoma, placenta .a 2037 to 2663 1 to 627       627/627
(100 %)
1 diff
(99.9 %id)
BE731160 choriocarcinoma, placenta .a 2037 to 2830 1 to 777       779/981
(79 %)
33 diff
(96.7 %id)
BG822748 adenocarcinoma cell line, colon .a 2064 to 2722 1 to 659       659/659
(100 %)
4 diff
(99.4 %id)
TI_927043836   .a 2079 to 3286 26 to 1222       1197/1274
(93 %)
22 diff
(98.3 %id)
BM756908 Ascites, stomach .a 2083 to 2700 1 to 618       618/618
(100 %)
0 diff
(100 %id)
BM756923 Ascites, stomach .a 2083 to 2398 1 to 316       316/316
(100 %)
1 diff
(99.7 %id)
BM767268 Ascites, stomach .a 2083 to 2765 1 to 683       683/683
(100 %)
0 diff
(100 %id)
BM745568 Ascites, stomach .a 2084 to 2525 1 to 442       442/442
(100 %)
5 diff
(98.9 %id)
BI092354 cervix .a 2097 to 2686 11 to 596       586/596
(98 %)
11 diff
(98.2 %id)
BM465315 eye, retinoblastoma .a 2131 to 2688 158 to 719       562/1289
(43 %)
20 diff
(98.5 %id)
BG198542   .a 2148 to 2732 21 to 613       591/856
(69 %)
43 diff
(95.0 %id)
BG198543   .a 2149 to 2890 41 to 778       738/854
(86 %)
26 diff
(97.0 %id)
BG190463   .a 2150 to 2791 40 to 683       644/844
(76 %)
22 diff
(97.4 %id)
BG185148   .a 2152 to 2284 150 to 18     Submitted on the opposite strand 133/150
(88 %)
0 diff
(100 %id)
BG187237   .a 2152 to 2483 1 to 332       332/334
(99 %)
6 diff
(98.3 %id)
BG193000   .a 2152 to 2960 1 to 808       808/809
(99 %)
12 diff
(98.6 %id)
BG212628   .a 2152 to 2903 1 to 748       748/753
(99 %)
6 diff
(99.3 %id)
BI869945 adenocarcinoma, cell line, Liver .a 2158 to 2910 1 to 752       752/752
(100 %)
1 diff
(99.9 %id)
TI_57228767   .a 2158 to 2910 56 to 807       752/752
(100 %)
1 diff
(99.9 %id)
CR746530 embryonal carcinoma, cell line, testis .a 2168 to 2675 7 to 514       508/514
(98 %)
6 diff
(98.9 %id)
CB147639 Liver .a 2170 to 2797 1 to 628       628/628
(100 %)
2 diff
(99.7 %id)
BQ222962 embryonal carcinoma, cell line, testis .a 2174 to 3027 1 to 858       858/859
(99 %)
6 diff
(99.4 %id)
CX872498 embryonic stem .a 2178 to 2947 1 to 770       770/770
(100 %)
0 diff
(100 %id)
BM828884 Ascites, stomach .a 2184 to 2649 1 to 466       466/466
(100 %)
1 diff
(99.8 %id)
TI_2194577133   .a 2194 to 3336 1 to 1135       1135/1266
(89 %)
18 diff
(98.6 %id)
BF904724 marrow .a 2197 to 2571 1 to 375       375/375
(100 %)
4 diff
(99.0 %id)
TI_927043842   .a 2202 to 3332 1 to 1129       1129/1268
(89 %)
3 diff
(99.8 %id)
BM904484 leiomyosarcoma, uterus .a 2204 to 2849 1 to 647       647/1145
(56 %)
17 diff
(98.6 %id)
BM761262 myeloma .a 2215 to 2779 1 to 565       565/565
(100 %)
0 diff
(100 %id)
BQ683254 melanotic melanoma, cell line, skin .a 2235 to 3148 1 to 917       917/931
(98 %)
10 diff
(99.0 %id)
BQ682689 melanotic melanoma, cell line, skin .a 2235 to 3120 1 to 887       887/911
(97 %)
7 diff
(99.3 %id)
TI_2194576666   .a 2241 to 3336 1197 to 116       1082/1297
(83 %)
18 diff
(98.7 %id)
BP265573 thyroid .a 2247 to 2826 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
DT215654 brain .a 2250 to 2848 1 to 599       599/599
(100 %)
0 diff
(100 %id)
TI_2194575665   .a 2266 to 3336 1179 to 116       1064/1264
(84 %)
14 diff
(98.9 %id)
BI258496 cervical carcinoma cell line, cervix .a 2302 to 3120 1 to 822       822/907
(90 %)
11 diff
(98.8 %id)
AA332056 Embryo, 8 weeks .a 2311 to 2629 1 to 319       319/319
(100 %)
0 diff
(100 %id)
DB358405 whole embryo, mainly head .a 2372 to 2946 569 to 1       569/602
(94 %)
12 diff
(98.1 %id)
TI_927043227   .a 2375 to 3336 1042 to 92     Submitted on the opposite strand 951/1190
(79 %)
14 diff
(98.9 %id)
TI_927043228   .a 2375 to 3336 1040 to 93     Submitted on the opposite strand 948/1195
(79 %)
18 diff
(98.5 %id)
BQ064703 lymph, lymphoma, cell line .a 2381 to 3274 1 to 905       903/966
(93 %)
21 diff
(97.9 %id)
TI_1948079948   .a 2387 to 3317 1042 to 118       925/1139
(81 %)
23 diff
(98.0 %id)
BF084841 denis_drash .a 2393 to 3032 1 to 638       638/657
(97 %)
20 diff
(97.0 %id)
BG986100 denis_drash .a 2393 to 3032 1 to 638       638/657
(97 %)
20 diff
(97.0 %id)
BF034631 adenocarcinoma, ovary .a 2398 to 3173 1 to 770       770/964
(79 %)
38 diff
(96.1 %id)
TI_1948079597   .a 2423 to 3317 1008 to 107       902/1323
(68 %)
34 diff
(97.5 %id)
AL578954 placenta .a 2461 to 3351 908 to 20       889/959
(92 %)
38 diff
(96.1 %id)
AI628901 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2469 to 2946 478 to 1       478/478
(100 %)
0 diff
(100 %id)
TI_1948079947   .a 2475 to 3317 965 to 119       847/1394
(60 %)
9 diff
(99.4 %id)
TI_1948078906   .a 2487 to 3317 938 to 119       820/1098
(74 %)
17 diff
(98.5 %id)
TI_1948079250   .a 2487 to 3317 945 to 117       829/1112
(74 %)
15 diff
(98.7 %id)
CF139440 CNCAP(3)T-225 cell line, Prostate .a 2502 to 3020 1 to 519       519/526
(98 %)
6 diff
(98.9 %id)
TI_154169644   .a 2509 to 3098 86 to 679       594/1084
(54 %)
8 diff
(99.3 %id)
TI_2194575658   .a 2519 to 3336 932 to 118       815/1117
(72 %)
5 diff
(99.6 %id)
AU149573   .a 2542 to 3399 857 to 1       857/888
(96 %)
14 diff
(98.5 %id)
TI_1948079598   .a 2542 to 3317 891 to 119       773/1137
(67 %)
15 diff
(98.7 %id)
BG186642   .a 2551 to 3373 823 to 11     Submitted on the opposite strand 813/891
(91 %)
33 diff
(96.3 %id)
BG193948   .a 2554 to 3374 830 to 13     Submitted on the opposite strand 818/851
(96 %)
21 diff
(97.6 %id)
TI_1948079249   .a 2555 to 3317 893 to 119       773/1320
(58 %)
53 diff
(96.0 %id)
TI_1948231771   .a 2556 to 3317 892 to 130       763/1438
(53 %)
6 diff
(99.6 %id)
BG216286   .a 2567 to 3372 817 to 12     Submitted on the opposite strand 806/855
(94 %)
56 diff
(93.5 %id)
FN144843 breast carcinoma .a 2571 to 2670 101 to 1     Submitted on the opposite strand 101/101
(100 %)
1 diff
(99.1 %id)
BG204201   .a 2574 to 3373 799 to 11     Submitted on the opposite strand 789/851
(92 %)
26 diff
(97.0 %id)
AA496720.
matches multiple genes
  .a 2591 to 3032 442 to 1     also hits gene THUMPD2 442/442
(100 %)
2 diff
(99.6 %id)
TI_1948078905   .a 2626 to 3317 820 to 126       695/1399
(49 %)
32 diff
(97.8 %id)
CA430279 cell lines, Chondrosarcoma .a 2640 to 3399 774 to 19   AAA   756/756
(100 %)
5 diff
(99.4 %id)
CA423579 cell lines, Chondrosarcoma .a 2641 to 3388 761 to 19   AAA   743/744
(99 %)
6 diff
(99.2 %id)
AW386545 pnet .a 2650 to 3094 1 to 446       446/446
(100 %)
12 diff
(97.4 %id)
AW386674 pnet .a 2650 to 3115 1 to 465       465/478
(97 %)
8 diff
(98.4 %id)
AW386400 pnet .a 2653 to 3031 1 to 380       380/380
(100 %)
13 diff
(96.6 %id)
AW386676 pnet .a 2655 to 3014 1 to 358       358/358
(100 %)
10 diff
(97.3 %id)
AW386399 pnet .a 2656 to 3098 1 to 444       444/444
(100 %)
7 diff
(98.5 %id)
AW386540 pnet .a 2657 to 3115 10 to 469       460/482
(95 %)
10 diff
(98.0 %id)
AW386541 pnet .a 2657 to 3115 7 to 465       459/478
(96 %)
8 diff
(98.4 %id)
AW386546 pnet .a 2657 to 3115 9 to 468       460/481
(95 %)
7 diff
(98.6 %id)
AW386548 pnet .a 2657 to 2889 10 to 242       233/242
(96 %)
10 diff
(95.9 %id)
AW386633 pnet .a 2657 to 3115 13 to 472       460/485
(94 %)
8 diff
(98.4 %id)
AW386675 pnet .a 2657 to 3115 18 to 473       456/486
(93 %)
15 diff
(97.0 %id)
AW386462 pnet .a 2661 to 3115 1 to 455       455/468
(97 %)
2 diff
(99.6 %id)
BF699903 brain, primitive neuroectoderm .a 2663 to 3375 1 to 704       702/869
(80 %)
33 diff
(96.3 %id)
AW386459 pnet .a 2664 to 3115 1 to 452       452/465
(97 %)
2 diff
(99.6 %id)
BF361388 pnet .a 2664 to 3032 1 to 372       372/375
(99 %)
19 diff
(95.0 %id)
AW386290 pnet .a 2669 to 3115 1 to 447       447/460
(97 %)
6 diff
(98.7 %id)
TI_927043843   .a 2679 to 3336 1 to 657       657/1242
(52 %)
5 diff
(99.6 %id)
AW386293 pnet .a 2688 to 3115 1 to 428       428/441
(97 %)
1 diff
(99.8 %id)
BM450980 eye, retinoblastoma .a 2692 to 3399 1 to 708   AAA   708/708
(100 %)
0 diff
(100 %id)
AW386463 pnet .a 2699 to 3014 1 to 316       316/316
(100 %)
4 diff
(98.8 %id)
BU632099 cell lines, Chondrosarcoma .a 2719 to 3399 696 to 16   AAA   681/681
(100 %)
2 diff
(99.8 %id)
CA428720 Cell Line, Chondrosarcoma .a 2720 to 3396 693 to 17   AAA   677/677
(100 %)
2 diff
(99.8 %id)
CV380552 pnet .a 2722 to 3095 12 to 367       356/367
(97 %)
22 diff
(94.1 %id)
BG194424   .a 2725 to 3373 663 to 13     Submitted on the opposite strand 651/821
(79 %)
26 diff
(96.9 %id)
TI_149285707   .a 2725 to 3396 757 to 86   AAA   672/703
(95 %)
4 diff
(99.5 %id)
BG196944   .a 2730 to 3372 656 to 14     Submitted on the opposite strand 643/860
(74 %)
7 diff
(99.2 %id)
BF034032 adenocarcinoma, ovary .a 2732 to 3391 1 to 662       662/664
(99 %)
4 diff
(99.4 %id)
BM971598 lung .a 2740 to 3396 673 to 17   AAA   657/657
(100 %)
0 diff
(100 %id)
AI630067 blood .a 2743 to 3016 1 to 277       277/277
(100 %)
9 diff
(96.8 %id)
AW386404 pnet .a 2750 to 3015 1 to 266       266/266
(100 %)
3 diff
(98.9 %id)
AW610565 denis_drash .a 2752 to 3082 1 to 339       339/339
(100 %)
28 diff
(91.8 %id)
CN309909 embryonic stem cells, DMSO-treated H9 cellline .a 2752 to 3318 1 to 567       567/567
(100 %)
0 diff
(100 %id)
BG396511 eye, retinoblastoma .a 2760 to 3403 1 to 646   AAA   646/646
(100 %)
9 diff
(98.7 %id)
BQ686501 ductal carcinoma, cell line, Pancreas .a 2762 to 3396 1 to 637   AAA   637/637
(100 %)
4 diff
(99.4 %id)
BU628139 Bone, Enchondroma cell line .a 2769 to 3399 649 to 19   AAA   631/631
(100 %)
1 diff
(99.9 %id)
BF349062 denis_drash .a 2782 to 3082 1 to 302       302/302
(100 %)
16 diff
(94.8 %id)
AW236853 pooled germ cell tumors .a 2789 to 3399 611 to 1       611/611
(100 %)
2 diff
(99.7 %id)
FN083396 breast carcinoma .a 2793 to 2888 1 to 94       94/94
(100 %)
3 diff
(96.9 %id)
AU150578   .a 2817 to 3399 581 to 1       581/581
(100 %)
21 diff
(96.4 %id)
AU151440   .a 2819 to 3399 582 to 1       582/584
(99 %)
5 diff
(99.2 %id)
AI761782 colon, colon tumor, RER+ .a 2824 to 3399 576 to 1       576/576
(100 %)
2 diff
(99.7 %id)
AU149075   .a 2826 to 3396 569 to 1       569/569
(100 %)
4 diff
(99.3 %id)
BQ930951 carcinoma, cell line, Prostate .a 2829 to 3389 119 to 680   AAA   562/680
(82 %)
11 diff
(98.4 %id)
BQ957430 carcinoma, cell line, Prostate .a 2831 to 3388 58 to 616   AAA   559/616
(90 %)
10 diff
(98.4 %id)
AW386593 pnet .a 2839 to 3115 299 to 24       276/299
(92 %)
3 diff
(99.0 %id)
AU150909   .a 2842 to 3388 548 to 1       548/560
(97 %)
8 diff
(98.6 %id)
AU152956   .a 2860 to 3399 544 to 1       542/544
(99 %)
11 diff
(98.0 %id)
BI870208 adenocarcinoma, cell line, Liver .a 2868 to 3399 1 to 532   AAA   532/532
(100 %)
3 diff
(99.5 %id)
TI_57229200   .a 2868 to 3401 73 to 606   AAA   534/647
(82 %)
4 diff
(99.4 %id)
BE542926 cervix .a 2881 to 3391 1 to 511       511/511
(100 %)
0 diff
(100 %id)
BG198460   .a 2888 to 3394 3 to 509   AAA   507/509
(99 %)
17 diff
(96.7 %id)
BE539229 cervix .a 2891 to 3389 1 to 497   available from MGC,   497/497
(100 %)
3 diff
(99.4 %id)
AL527731 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 2892 to 3392 1 to 501   fully sequenced,   501/501
(100 %)
1 diff
(99.9 %id)
EC499614 Prostate .a 2892 to 2979 1 to 90       90/90
(100 %)
2 diff
(97.8 %id)
BC002337 Placenta, choriocarcinoma .a 2893 to 3394 1 to 502   available from MGC, AAA   502/502
(100 %)
0 diff
(100 %id)
AI354451 ovary, tumor, 5 pooled (see description) .a 2927 to 3399 473 to 1       473/473
(100 %)
0 diff
(100 %id)
DB516837 testis .a 2933 to 3393 1 to 461     Submitted on the opposite strand 461/464
(99 %)
1 diff
(99.8 %id)
AW172296 pooled .a 2957 to 3394 450 to 13   AAA   438/438
(100 %)
2 diff
(99.6 %id)
TI_2194577127   .a 2961 to 3336 4 to 377       374/1255
(29 %)
7 diff
(99.5 %id)
TI_154059060   .a 2965 to 3383 1129 to 712       418/609
(68 %)
55 diff
(91.0 %id)
AA827175 germinal center B cell .a 2973 to 3388 427 to 13   AAA   415/415
(100 %)
1 diff
(99.8 %id)
BF109445 pooled .a 3004 to 3392 393 to 5       389/393
(98 %)
0 diff
(100 %id)
BI258237 cervical carcinoma cell line, cervix .a 3016 to 3394 12 to 390   AAA   379/390
(97 %)
6 diff
(98.5 %id)
AW673859 cervix .a 3027 to 3397 371 to 1       371/371
(100 %)
0 diff
(100 %id)
AI039522   .a 3029 to 3398 371 to 2       370/371
(99 %)
0 diff
(100 %id)
BG777758 adenocarcinoma, Prostate .a 3056 to 3388 1 to 333   AAA   333/333
(100 %)
1 diff
(99.7 %id)
CA335984 anterior rhombomeres 1-4 (4 pooled) .a 3069 to 3400 1 to 332   AAA   332/332
(100 %)
2 diff
(99.4 %id)
CB217730 mandible, pooled .a 3069 to 3615 1 to 547   fully sequenced,   547/547
(100 %)
3 diff
(99.5 %id)
CB217822 mandible, pooled .a 3069 to 3388 1 to 320   fully sequenced, AAA   320/320
(100 %)
2 diff
(99.4 %id)
CB409586 maxilla, pooled .a 3069 to 3388 1 to 320   AAA   320/320
(100 %)
1 diff
(99.7 %id)
AL527730 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 3089 to 3374 286 to 1   fully sequenced,   286/286
(100 %)
2 diff
(99.4 %id)
CB217821 mandible, pooled .a 3089 to 3388 335 to 36   fully sequenced, AAA   300/300
(100 %)
2 diff
(99.4 %id)
BM874416   .a 3092 to 3388 1 to 297   AAA   297/297
(100 %)
0 diff
(100 %id)
BE833448 ovary .a 3108 to 3314 7 to 214       208/223
(93 %)
2 diff
(99.2 %id)
BE011481 breast_normal .a 3115 to 3327 234 to 24     Submitted on the opposite strand 211/240
(87 %)
1 diff
(99.6 %id)
BG943184 blood .a 3121 to 3397 1 to 277   AAA   277/277
(100 %)
1 diff
(99.7 %id)
BE011489 breast_normal .a 3124 to 3351 236 to 11     Submitted on the opposite strand 226/236
(95 %)
0 diff
(100 %id)
BE816391 breast_normal .a 3124 to 3351 6 to 235       230/245
(93 %)
14 diff
(94.3 %id)
BE816416 breast_normal .a 3124 to 3344 225 to 4       222/225
(98 %)
0 diff
(100 %id)
BE816420 breast_normal .a 3124 to 3335 229 to 10       220/229
(96 %)
1 diff
(99.6 %id)
BE816439 breast_normal .a 3124 to 3339 215 to 1       215/215
(100 %)
2 diff
(99.1 %id)
BI254583 cervical carcinoma cell line, cervix .a 3133 to 3379 13 to 260   AAA   248/282
(87 %)
8 diff
(97.2 %id)
DB516037 testis .a 3169 to 3385 1 to 217     Submitted on the opposite strand 217/220
(98 %)
1 diff
(99.6 %id)
AW468663 pooled .a 3184 to 3396 224 to 12   AAA   213/213
(100 %)
0 diff
(100 %id)
BM987728 mixed .a 3187 to 3388 220 to 19   AAA   202/202
(100 %)
0 diff
(100 %id)
BM873985   .a 3188 to 3388 215 to 15   AAA   201/201
(100 %)
0 diff
(100 %id)
FN126666 breast carcinoma .a 3226 to 3292 1 to 69       69/74
(93 %)
2 diff
(97.3 %id)
AI798526 ovary, tumor, 5 pooled (see description) .a 3237 to 3394 158 to 1       158/185
(85 %)
0 diff
(100 %id)
CD523221 pooled .a 3238 to 3389 1 to 152   AAA   152/152
(100 %)
3 diff
(98.1 %id)
C21288   .a 3302 to 3399 1 to 98       98/98
(100 %)
0 diff
(100 %id)
BM743260 stomach .a 3329 to 3925 1 to 597   tiling clone,   597/597
(100 %)
0 diff
(100 %id)
TI_154071526   .a 3410 to 3985 667 to 91   AAA   577/577
(100 %)
20 diff
(96.6 %id)
DB370624   .a 3418 to 3985 570 to 1       570/572
(99 %)
22 diff
(96.2 %id)
AW103118 pooled .a 3430 to 3987 562 to 3       560/564
(99 %)
0 diff
(100 %id)
CR742104 pooled .a 3440 to 4096 1 to 660       660/660
(100 %)
8 diff
(98.8 %id)
AI341607 pooled germ cell tumors .a 3580 to 3987 408 to 1       408/408
(100 %)
0 diff
(100 %id)
BE502069 pooled germ cell tumors .a 3580 to 3987 408 to 1       408/408
(100 %)
2 diff
(99.6 %id)
CB217729 mandible, pooled .a 3585 to 3991 459 to 53   fully sequenced,   407/459
(88 %)
9 diff
(98.1 %id)
AA705810   .a 3593 to 3985 407 to 15   AAA   393/393
(100 %)
0 diff
(100 %id)
AI873407 pooled .a 3658 to 3985 347 to 19       329/347
(94 %)
0 diff
(100 %id)
BE551709 pooled germ cell tumors .a 3662 to 3985 333 to 9       325/333
(97 %)
0 diff
(100 %id)
BF367839 placenta_normal .a 3713 to 4026 1 to 315       315/315
(100 %)
5 diff
(98.5 %id)
AI873375 pooled .a 3725 to 3987 265 to 3       263/265
(99 %)
0 diff
(100 %id)
BF367842 placenta_normal .a 3731 to 4026 1 to 296       296/296
(100 %)
2 diff
(99.4 %id)
DB134444 thymus .a 3908 to 4462 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
CA335931 anterior rhombomeres 1-4 (4 pooled) .a 3970 to 4482 1 to 513       513/513
(100 %)
0 diff
(100 %id)
N88041   .a 3984 to 4209 1 to 226       226/226
(100 %)
2 diff
(99.2 %id)
AW573158 pooled .a 4298 to 4750 454 to 1       454/454
(100 %)
1 diff
(99.8 %id)
BG398543 B-cells, primary B-cells from tonsils (cell line) .a 4366 to 4750 1 to 384   AAA   384/384
(100 %)
2 diff
(99.5 %id)
AA640134 breast .a 4416 to 4749 334 to 1   tiling clone,   334/334
(100 %)
0 diff
(100 %id)
AA972447 pooled .a 4505 to 4894 390 to 1   tiling clone,   390/390
(100 %)
0 diff
(100 %id)
TI_2194575644   .b 1 to 886 86 to 968       883/1183
(74 %)
13 diff
(99.0 %id)
TI_2194575651   .b 1 to 935 86 to 1011       926/1164
(79 %)
20 diff
(98.3 %id)
TI_2194576285   .b 1 to 1089 89 to 1165       1077/1236
(87 %)
25 diff
(98.0 %id)
BC143383 Lung and heart, PCR rescued clones .b 1 to 3017 1 to 3017 exact tiling clone,   3017/3017
(100 %)
1 diff
(100.0 %id)
TI_2194577129   .b 239 to 1417 1 to 1170       1170/1250
(93 %)
22 diff
(98.3 %id)
TI_2194577130   .b 662 to 1835 17 to 1179       1163/1261
(92 %)
30 diff
(97.7 %id)
TI_2194577126   .b 1040 to 2174 1 to 1132       1132/1237
(91 %)
15 diff
(98.8 %id)
TI_2194577131   .b 1095 to 2237 15 to 1150       1136/1239
(91 %)
15 diff
(98.8 %id)
BQ228518 embryonal carcinoma, cell line, testis .c 1 to 881 1 to 886   tiling clone,   886/886
(100 %)
16 diff
(98.2 %id)
BE783497 eye, retinoblastoma .c 158 to 769 1 to 606       606/734
(82 %)
21 diff
(97.2 %id)
TI_2194577132   .c 201 to 1308 1 to 1084   tiling clone,   1089/1211
(89 %)
28 diff
(97.7 %id)
BU620646 cell lines, Chondrosarcoma .c 1213 to 1862 665 to 16   tiling clone, AAA   650/650
(100 %)
3 diff
(99.6 %id)
BG202075   .c 1324 to 1851 1 to 529   tiling clone, AAA   529/529
(100 %)
11 diff
(98.0 %id)
BQ215869 embryonal carcinoma, cell line, testis .d 1 to 747 1 to 753 F227C E228* tiling clone, AAA   753/761
(98 %)
6 diff
(99.3 %id)
AW503468 lymph .e 1 to 537 7 to 543 exact tiling clone,   537/543
(98 %)
1 diff
(99.9 %id)
TI_154159406   .e 1 to 665 88 to 752 exact tiling clone,   665/666
(99 %)
5 diff
(99.3 %id)
AI954042 normal epithelium, ovary .f 1 to 417 417 to 1 exact tiling clone,   417/417
(100 %)
0 diff
(100 %id)
AL601558   .g-u 1 to 699 1 to 699 exact tiling clone,   699/699
(100 %)
3 diff
(99.6 %id)
CN309914 embryonic stem cells, DMSO-treated H9 cellline .h-u 1 to 523 1 to 523 exact tiling clone,   523/523
(100 %)
6 diff
(98.9 %id)
DB154890 thymus .i-u 1 to 516 2 to 517 exact tiling clone, capped   516/518
(99 %)
1 diff
(99.9 %id)
AI829160 adenocarcinoma, Pancreas .j-u 1 to 402 402 to 1 K2* tiling clone,   402/402
(100 %)
4 diff
(99.1 %id)
BX502627 Liver Gene NCAPG, variant not shown         This clone was ignored    
BX502628 Liver Gene NCAPG, variant not shown       AAA This clone was ignored    
DA508450 brain Gene NCAPG, variant not shown       capped Suspected internal deletion, this clone was ignored    
AI914424 pooled Gene NCAPG, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BM904882 melanotic melanoma, skin Gene NCAPG, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h-u, .i-u, .j-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI